Clinical Outcomes of Tanezumab With Different Dosages for Patient With Osteoarthritis: Network Meta-Analysis

Background: Osteoarthritis (OA) high disability rate will increase as people getting older, and is the most prevalent form of arthritis in the future. This study identified the clinical effects of optimum doses of tanezumab for patients with OA. Method: Three electronic databases were searched up un...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Rui, Song, Ya-Feng, Yang, Zhi-Yan, Zhang, Chao, Tan, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232525/
https://www.ncbi.nlm.nih.gov/pubmed/34177562
http://dx.doi.org/10.3389/fphar.2021.614753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232525/
https://www.ncbi.nlm.nih.gov/pubmed/34177562
http://dx.doi.org/10.3389/fphar.2021.614753

Ejemplares similares